Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115108493 | 11510849 | 3 | F | 201404 | 20160720 | 20150915 | 20160802 | EXP | US-JUBILANT CADISTA PHARMACEUTICALS-2015JUB00276 | JUBILANT | 22.88 | YR | F | Y | 56.00000 | KG | 20160802 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115108493 | 11510849 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 500 MG, 2X/DAY | U | 90661 | 500 | MG | BID | ||||||
| 115108493 | 11510849 | 2 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | U | 90661 | |||||||||||
| 115108493 | 11510849 | 3 | C | IMURAN | AZATHIOPRINE | 1 | 50 MG, 1X/DAY | 0 | 50 | MG | QD | ||||||||
| 115108493 | 11510849 | 4 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 200 MG, 1X/DAY | 0 | 200 | MG | QD | ||||||||
| 115108493 | 11510849 | 5 | C | OSCAL | CALCIUM CARBONATE | 1 | 1250 MG, 1X/DAY | 0 | 1250 | MG | QD | ||||||||
| 115108493 | 11510849 | 6 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 325 MG, 1X/DAY | 0 | 325 | MG | QD | ||||||||
| 115108493 | 11510849 | 7 | C | PRENATAL VITAMINS | VITAMINS | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
| 115108493 | 11510849 | 8 | C | PREDNISONE. | PREDNISONE | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | QD | ||||||||
| 115108493 | 11510849 | 9 | C | BACTROBAN OINTMENT 2% | 2 | Topical | UNK | 0 | |||||||||||
| 115108493 | 11510849 | 10 | C | CULTURELLE PROBIOTIC | 2 | 1 CAPSULES, 3X/DAY | 0 | 1 | DF | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115108493 | 11510849 | 1 | Juvenile idiopathic arthritis |
| 115108493 | 11510849 | 2 | Dermatomyositis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115108493 | 11510849 | HO |
| 115108493 | 11510849 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115108493 | 11510849 | Exposure during pregnancy | |
| 115108493 | 11510849 | Hospitalisation | |
| 115108493 | 11510849 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115108493 | 11510849 | 1 | 201404 | 20150817 | 0 |